Novozymes A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NVZMY research report →
About the company
Novozymes A/S is a global biotechnology firm that specializes in the creation and distribution of industrial enzymes, microorganisms, and probiotics. Its operational footprint spans across Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific region. The company's broad range of products caters to numerous sectors: Food and Beverages: Supplying ingredients and processing aids for baking, a variety of beverages, dairy production, starch modification, and protein applications.
- CEO
- Ester Baiget
- IPO
- 2010
- Employees
- 10,582
- HQ
- Bagsvaerd, DK
Price Chart
- Market Cap
- $30.35B
- P/E
- 43.23
- P/S
- 6.33
- P/B
- 2.44
- EV/EBITDA
- 19.70
- Div Yield
- 1.52%
- Gross Margin
- 54.33%
- Op Margin
- 20.85%
- Net Margin
- 14.21%
- ROE
- 5.52%
- ROIC
- 4.44%
- Revenue
- $4.16B · 709.42%
- Net Income
- $583.60M · 1324.31%
- EPS
- $1.35 · 800.00%
- Op Income
- $882.60M
- FCF YoY
- 13.73%
- 52W High
- $73.18
- 52W Low
- $49.90
- 50D MA
- $59.75
- 200D MA
- $60.81
- Beta
- 0.62
- Avg Volume
- 53.59K
Get TickerSpark's AI analysis on NVZMY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our NVZMY coverage
Recent articles, reports, and earnings notes.
No research on NVZMY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NVZMY report →Similar companies
Peers in the same neighborhood.